Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase 3 5Phase NA 3Phase 2/3 2Phase 1/2 2Phase 1 2

Status

Unknown 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Non-Small-Cell Lung 18Breast Neoplasms 15Pancreatic Neoplasms 13Colorectal Neoplasms 10Rectal Neoplasms 7Stomach Neoplasms 6Neoplasm Metastasis 6Lung Neoplasms 6Neoplasms 5Recurrence 4Ovarian Neoplasms 4Uterine Cervical Neoplasms 3Small Cell Lung Carcinoma 3Prostatic Neoplasms 3Lymphoma, T-Cell, Peripheral 3Leukemia, Myeloid, Acute 3Esophageal Squamous Cell Carcinoma 3Colonic Neoplasms 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Treatment 2Solid Tumor 2Small Cell Lung Cancer Limited Stage 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Multiple Myeloma 2Lymphoma 2Head and Neck Neoplasms 2Glioma 2Glioblastoma 2Esophageal Neoplasms 2

Interventions

Radiotherapy 8camrelizumab 3Drug Therapy 3Cisplatin 3sintilimab 2Paclitaxel 2Neoadjuvant Therapy 2toripalimab 1tislelizumab 1pembrolizumab 1durvalumab 1anlotinib 1Surgical Procedures, Operative 1Radiofrequency Ablation 1Radiation 1Poly(ADP-ribose) Polymerase Inhibitors 1Observation 1Narrow Band Imaging 1Magnetic Resonance Spectroscopy 1Laparoscopy 1Immune Checkpoint Inhibitors 1Gene Expression Profiling 1Fluorouracil 1Fluorodeoxyglucose F18 1Esophagectomy 1Endoscopy, Digestive System 1Docetaxel 1Consolidation Chemotherapy 1Chemoradiotherapy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Esophageal Squamous Cell Carcinoma × Drug Therapy × Clear all
NCT06048926 2023-09-21

Carrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell Carcinoma

The First Affiliated Hospital with Nanjing Medical University

Phase NA Enrolling by invitation
30 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05199649 2022-01-20

Correlation Between the Efficacy of Neoadjuvant Chemotherapy Combined With Immunotherapy of Operable Thoracic Esophageal Squamous Cell Carcinoma and the Metabolites of Intestinal Flora

The First Affiliated Hospital of Soochow University

Phase NA Unknown
30 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT00004867 2017-01-24

Positron Emission Tomography in Determining Stage of Esophageal Cancer

Alliance for Clinical Trials in Oncology

Phase NA Completed
235 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡